The decidual tissue was

collected in Tris–Hank’s solution and kept on ice for a short time until processing. Monoclonal antibodies against CD45-FITC/CD14-PE (clone T29/33 and TUK4), CD4 and CD4-FITC (clone MT310), CD25-PE (clone ACT-1), CD45RO (clone UCHT-1), IgG Fab-FITC (clone F0479), epithelial cell antigen (clone Ber-EP4), and Streptavidin-PE were purchased from DAKO Norden A/S, Glostrup, Denmark; mAbs against Foxp3-PE, CD4-FITC, and CD25-APC were purchased from eBioscience (San Diego, CA, USA); mAbs against Foxp3 (clone 263A/E7) from Abcam, Epigenetics Compound Library research buy Cambridge, UK, neuropilin-1 from Santa Cruz Biotechnology (Santa Cruz, CA, USA), LAG-3 (clone 12H6) from Novocastra Laboratories, Newcastle upon Thyne, UK, CTLA-4 (clone BNI3) and CD56 (clone MY31) from BD Biosciences Pharmingen (Franklin Lakes, NJ, USA), CD62L (clone FMC46) from Serotec (Düsseldorf, Germany), CD103-FITC (clone 2G5) from Eurobiosciences (Friesoythe, Germany), pan-γδ-FITC (clone 5A6.E9) and Vδ1-FITC (clone TS8.2) from Endogen (Thermo

Fisher Scientific Inc., Rockford, IL, USA); and mouse serum, goat-anti-mouse IgG-Fab, peroxidase-conjugated goat-anti-mouse IgG-Fab and biotinylated goat-anti-mouse IgG-Fab from Jackson Immuno Research Laboratories Inc., West Grove, PA, USA. Five decidual samples were fixed in HOPE solution (Innovative Diagnostic System), and paraffin embedded according to manufacturer’s instructions. Double staining of CD4 and Foxp3 was performed Autophagy Compound Library datasheet using primary mAbs against CD4 (MT310, 1:10) and Foxp3 (263A/E7, 1:2) and the anti-mouse ImmPress peroxidase kit (Vector Laboratories,

Burlingame, CA, USA). In brief, dewaxed and rehydrated sections were blocked with 2.5% horse serum for 30 min at room temperature (rt). The first primary mAb (anti-CD4) was applied for 1 hr followed by endogenous peroxidase blocking with 0.03% H2O2 and washing. The slides were then incubated with anti-mouse horse-radish peroxidase polymer (ImmPress) for 30 min at rt, and a brown color reaction was developed by 3,3-diaminobenzidine tetrahydrochloride (DAB, 0.5 mg/ml; Sigma Aldrich, St Louis, MO, USA) in 0.05 m Tris–HCl Cobimetinib solution, pH 7.6, containing 0.03% H2O2. To reduce background staining and non-specific binding, the slides were incubated with mouse IgG (1:10) for 30 min and goat anti-mouse Fab (1:50) for 60 min.35 Anti-Foxp3 mAb was applied overnight at 4°C followed by a second step of endogenous peroxidase blocking and an incubation with ImmPress peroxidase polymer for 40 min at rt. A specific red color reaction was developed by adding of aminoethylcarbazole (AEC; Sigma Aldrich) in Na acetate buffer with 3% H2O2 for 30 min at rt. In the single stain procedure, only one incubation with the primary antibody anti-Foxp3 was carried out. The slides were counterstained with methyl green, mounted, and examined in light microscope.